“Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice” (2008) Farmeconomia. Health economics and therapeutic pathways, 9(4), pp. 173–181. doi:10.7175/fe.v9i4.235.